C4 Therapeutics CCCC
NASDAQ CCCC
$3.77 +0.03 (+0.80%)
As of: Sep 4, 2026 · 2:24 PM EDT

C4 Therapeutics (CCCC) Total Debt (QoQ) (2020 - 2023)

Analysis

C4 Therapeutics (CCCC) Total Debt (QoQ) (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 C4 Therapeutics 492.73 Mn 239.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 47.25%
Mar 31, 2023 1.95%
Dec 31, 2022 1.60%
Sep 30, 2022 14.15%
Jun 30, 2022 8.48%
Mar 31, 2022 1.63%
Dec 31, 2021 1.70%
Sep 30, 2021 1.72%
Jun 30, 2021 1.74%
Mar 31, 2021 1.78%
Dec 31, 2020 1.77%